QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

MYGN

QT72Myriad Genetics, Inc.
NASDAQ·Healthcare·Medical - Diagnostics & Research·USA
Latest market price
4.54
+0.16+3.65%
OverviewShort InterestFilings
MYGNQT72Myriad Genetics, Inc.·NASDAQ
OverviewShort InterestFilings
4.54+3.65%
TA
Loading chart...
Screen all →
TMO+0.63%$464.61DHR-0.33%$177.17IDXX+2.93%$562.09A+2.20%$127.06NTRA+2.19%$231.41IQV-1.70%$167.77ILMN+1.79%$161.93WAT-0.44%$355.44
Snapshot
Index-P/E-EPS (ttm)-4.30
Insider Own9.52%
Shs Outstand94.45M
Perf Week-1.94%
Market Cap413.68MForward P/E30.04EPS next Y0.15Insider Trans0.15%Shs Float-Perf Month27.89%
Enterprise Value500.78MPEG0.00EPS next Q-0.03Inst Own-Short Float-Perf Quarter-4.42%
Income-403092828.00P/S0.50EPS this Y101.42%Inst Trans-Short Ratio-Perf Half Y-34.01%
Sales828.97MP/B1.22EPS next Y146.71%ROA-59.36%Short Interest-Perf YTD-26.18%
Book/sh3.57P/C171.00EPS next 5Y79.79%ROE-109.09%52W High8.59 -47.15%Perf Year-8.84%
Cash/sh1.31P/FCF-EPS past 3/5Y-ROIC-69.65%52W Low3.53 28.61%Perf 3Y-
Dividend Est.-EV/EBITDA-1.50Sales past 3/5Y6.76% 8.17%Gross Margin69.96%Volatility3.62% 4.14%Perf 5Y-
Dividend TTM-EV/Sales0.60EPS Y/Y TTM90.78%Oper. Margin-46.26%ATR (14)0.28Perf 10Y-
Dividend Ex-DateJul 01, 2009Quick Ratio2.19Sales Y/Y TTM-1.07%Profit Margin-48.24%RSI (14)55.21Recom2.94
Dividend Gr. 3/5Y-Current Ratio2.40EPS Q/Q-SMA205.88%Beta1.51Target Price6.00
Payout0.00%Debt/Eq0.63Sales Q/Q2.04%SMA502.86%Rel Volume1.52Prev Close4.38
Employees2,700LT Debt/Eq0.55EarningsAug 04SMA200-22.58%Avg Volume1.61MPrice4.54
IPO DateOct 06, 1995Option/ShortYes / YesEPS/Sales Surpr.-50.00% -0.99%Net Debt/EBITDA-0.26Volume2,436,200Change3.65%
Analyst Ratings
DateActionAnalystRatingTarget
Feb-24-26ReiteratedUBSNeutral$8.00 → $6.00
Nov-04-25ReiteratedUBSNeutral$7.00 → $8.00
May-21-25DowngradeScotiabankSector Outperform → Sector Perform
May-08-25DowngradeWells FargoOverweight → Equal Weight$6.00
May-07-25ReiteratedCraig-Hallum$29 → $18
May-07-25ReiteratedUBSNeutral$7.00
Apr-09-25DowngradeGuggenheimBuy → Neutral
Mar-12-25UpgradePiper SandlerNeutral → Overweight$12 → $13
Mar-04-25ReiteratedPiper SandlerNeutral$28 → $12
Dec-09-24DowngradeLeerink PartnersOutperform → Market Perform$21
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
6/30/2020
FY 2018
6/30/2019
Total Revenue829825838
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A249248252
Gross Profit581577585
Selling, General and Administrative Excl. Other538538560
Research and Development107107113
Other Operating Expense319-136
Operating Income-383-68-123
Interest Expense14113
Unusual Expense
———
Non-Operating Income (Expense)3317-3
Net Income Before Taxes-400-395-123
Income Taxes0-294
Consolidated Net Income-399-366-127
Net Income From Continuing Operations-399-366-127
Net Income-399-366-127
EPS (Recurring)-4.30-3.96-1.41
EPS (Basic, Before Extraordinaries)-4.30-3.96-1.41
EPS (Diluted)-4.30-3.96-1.41
EBITDA-334-331-59
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio0.510.69—
Gross Margin70.0869.9469.81
Operating Margin-46.20-8.24-14.68
Net Margin-48.13-44.36-15.16
Shares Outstanding949391
Market Capitalization427572—
Operating Lease Expense
———
Insider Trading Volume
$4.89$4.37$3.85$3.33$2.81● Close Price0.00K123.68K247.36K371.04K494.72KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Kumar RashmiDirectorJun 08 '26Sale4.4615,00066,843171,889Jun 09 12:00 AM
Bisaro PaulDirectorMay 14 '26Buy3.697,50027,63897,441May 14 12:00 AM
Raha Samraat S.President and CEOMar 09 '26Buy5.0040,000199,844493,104Mar 09 12:00 AM
Phanstiel S. LouiseDirectorFeb 27 '26Buy4.6648,000223,728281,951Feb 27 12:00 AM
Phanstiel S. LouiseDirectorFeb 26 '26Buy4.8050,407242,105233,951Feb 27 12:00 AM
Phanstiel S. LouiseDirectorFeb 25 '26Buy4.746,10028,890183,544Feb 27 12:00 AM
DIAZ PAUL JPresident and CEOOct 11 '24Sale22.9315,000343,950962,378Oct 11 12:00 AM
DIAZ PAUL JPresident and CEOSep 11 '24Sale26.7215,000400,800977,378Sep 12 12:00 AM
Muzzey DaleChief Scientific OfficerSep 11 '24Sale26.172,10054,961108,013Sep 12 12:00 AM
Dreismann HeinrichDirectorSep 09 '24Sale27.0510,000270,520121,648Sep 09 12:00 AM
Reitan Colleen FDirectorSep 03 '24Sale27.9546,0121,285,85142,533Sep 04 12:00 AM
Ancona MargaretSVP, Chief of StaffAug 21 '24Sale27.8211,538320,98779,366Aug 23 12:00 AM
Kumar RashmiDirectorAug 19 '24Sale28.017,500210,07577,392Aug 20 12:00 AM
SPIEGELMAN DANIEL KDirectorJun 04 '24Sale22.053,78883,52532,917Jun 04 12:00 AM
SPIEGELMAN DANIEL KDirectorJun 03 '24Sale22.043,78883,48836,705Jun 04 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR